VMM

EPCM appointment by Sedgman/Blossom indicators transition from study to execution; pre-FID bridging phase (US$3m) commences immediately with detailed engineering and long-lead procurement to maintain 2028 production critical path. This is operationally material but capital-light ahead of Full Investment Decision.

VMM secured R$77.5M (~US$15M) non-dilutive, low-cost Brazilian government financing at 4.8% p.a. for its Poços de Caldas rare earth processing centre, reducing remaining Colossus capex debt to ~US$280M. The approval indicators state backing for domestic supply chain and de-risks near-term funding runway, but is largely reimbursement of already-incurred capex rather than fresh dry powder.

Viridis has placed the first major critical-path equipment order for Colossus, advancing from post-DFS feasibility into active project execution with a 52–56 week manufacturing lead time protecting the 2028 production target. The move indicators management confidence in financing and permits, but equity funding is already locked and the order is structured with limited pre-FID financial exposure, reducing the surprise.

OneIM (Rajeev Misra's vehicle) has accumulated 9.9% of VMM for ~$60.4m, signalling serious institutional conviction in the rare earths play. The stake is large enough to confer board influence and suggests confidence in VMM's asset base or near-term catalysts.

VMM voluntarily suspended pending Definitive Feasibility Study results, expected to re-quote Thursday 20 Aug—a material de-risking event for a $548m rare-earths developer. The 35% run-up into the halt indicators market confidence, but the DFS outcome remains binary.